Cyclacel Pharmaceuticals Inc CYCC:NASDAQ

Last Price$3.17Cboe Closing Price as of 3:59PM ET 1/27/22
Cboe Real-Time Quotes
Today's Change-0.03(0.94%)
Bid (Size)$2.92 (100)
Ask (Size)$3.36 (100)
Day Low / High$3.13 - 3.19
Volume55.6 K
 

View Biotechnology IndustryPeer Comparison as of 01/27/2022

 

Cyclacel Pharmaceuticals Inc ( NASDAQ )

Price: $3.17
Change: -0.03 (0.94%)
Volume: 55.6 K
3:59PM ET 1/27/2022
 
 

Calithera Biosciences Inc ( NASDAQ )

Price: $0.42
Change: -0.02 (3.52%)
Volume: 921.0 K
3:50PM ET 1/27/2022
 
 

Minerva Neurosciences Inc ( NASDAQ )

Price: $0.73
Change: -0.001 (0.16%)
Volume: 71.8 K
3:59PM ET 1/27/2022
 
 

Synthetic Biologics Inc ( NYSE MKT LLC )

Price: $0.23
Change: -0.02 (6.66%)
Volume: 1.2 M
3:50PM ET 1/27/2022
 
 

Navidea Biopharmaceuticals Inc ( NYSE MKT LLC )

Price: $0.95
Change: -0.06 (5.94%)
Volume: 59.9 K
3:58PM ET 1/27/2022
 

Read more news Recent News

-- Earnings Flash (CYCC) CYCLACEL Posts Q3 Revenue $4.2M
4:16PM ET 11/10/2021 MT Newswires

...

-- Earnings Flash (CYCC) CYCLACEL Posts Q3 Loss $-0.54, vs. Street Est of $-0.70
4:16PM ET 11/10/2021 MT Newswires

...

Cyclacel Starts Patient Dosing in Phase 1/2 Trial of Fadraciclib in Leukemias, Myelodysplastic Syndromes
10:22AM ET 11/05/2021 MT Newswires

Cyclacel Pharmaceuticals (CYCC) said Friday it has dosed the first patient in a phase 1/2 trial of oral fadraciclib in patients with leukemias or...

-- Earnings Flash (CYCC) CYCLACEL Reports Q2 Loss $-0.56, vs. Street Est of $-0.47
4:12PM ET 8/11/2021 MT Newswires

...

Company Profile

Business DescriptionCyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ. View company web site for more details
Address200 Connell Drive
Berkeley Heights, New Jersey 07922
Phone+1.908.517.7330
Number of Employees14
Recent SEC Filing12/16/20214/A
President, Chief Executive Officer & DirectorSpiro Rombotis
Secretary, Chief Operating & Financial OfficerPaul McBarron
Chief Medical Officer & Senior Vice PresidentMark Kirschbaum
Senior Director-Business DevelopmentAmartya Basu

Company Highlights

Price Open$3.19
Previous Close$3.20
52 Week Range$2.76 - 11.42
Market Capitalization$31.6 M
Shares Outstanding10.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.94
Beta vs. S&P 500N/A
Revenue$150.0 K
Net Profit MarginN/A
Return on Equity-39.54%

Analyst Ratings as of 11/20/2021

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset